Beit Jala Pharmaceutical Reports Third Quarter Financial Results Reflecting Moderate Challenges
Beit Jala Pharmaceutical (BJP) has disclosed its financial statements for the third quarter of the year 2026, revealing a period marked by moderate financial challenges. The company, operating within the designated market category of the pharmaceutica…